myUTSAUTSA TodayVisitDirectorySearch
myUTSAUTSA TodayVisitDirectorySearch

Biomedical Engineering

  • Programs
    • Program Overview
    • Undergraduate Program
      • Undergraduate Research
    • Joint Graduate Program
  • Faculty & Staff
  • Research
  • Contact
    • Department Information
  • News & Announcements
    • Seminars
UTSA COE
 February 28, 2021

Michael J. Yaszemski, M.D., Ph.D.

Michael J. Yaszemski, M.D., Ph.D.

by BMEngineer / Tuesday, 02 July 2019 / Published in
Professor
michael.yaszemski@utsa.edu
 

Professor

Department of Biomedical Engineering

Educational Background:

  • S., M.S., Chemical Engineering, Lehigh University, Bethlehem, PA
  • D., Medicine, Georgetown University, Washington, DC
  • D., Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA
  • Fellowship, Spine Surgery & Biomechanics, Harvard Medical School, Boston, MA

Areas of Teaching Interest:

  • Clinical Orthopedics
  • Tissue Engineering
  • Spine Surgery
  • Polymer Chemistry

Areas of Research Interest:

  • Synthesis and characterization of degradable polymers
  • Translational musculoskeletal research
  • Metastatic spine tumors
  • Bone tissue engineering
  • Nerve and spinal cord regeneration

Description of Research:

Dr. Michael J. Yaszemski is the Krehbiel Family Endowed Professor of Orthopedic Surgery and Biomedical Engineering at the Mayo Clinic and director of its Polymeric Biomaterials and Tissue Engineering Laboratory. He is a retired U.S. Air Force Brigadier General and served in the office of the Air Force Surgeon General and the office of the President of the Uniformed Services University of the Health Sciences prior to retiring in 2013. He is a member of The National Academy of Medicine and The National Academy of Inventors.  His clinical practice encompasses spine surgery and musculoskeletal oncology.

His research interests are in the synthesis and characterization of novel degradable polymers for use in bone regeneration, cartilage regeneration, nervous tissue regeneration, and controlled delivery of chemotherapeutic agents to musculoskeletal tumors. In specific, on-going projects focus on developing novel minimally invasive methods for the prediction of fracture risk in metastatic spine tumors, nerve guidance conduit development, novel biomaterials for musculoskeletal use, and bone tissue engineering.

Selected Publications

  • Becker J, Lu L, Runge MB, Zeng H, Yaszemski MJ, Dadsetan M. Nanocomposite bone scaffolds based on biodegradable polymers and hydroxyapatite. Journal of Biomedical Materials Research Part A. 2015 Aug;103(8):2549-57.
  • Dadsetan M, Guda T, Runge MB, Mijares D, LeGeros RZ, LeGeros JP, Silliman DT, Lu L, Wenke JC, Baer PR, Yaszemski MJ. Effect of calcium phosphate coating and rhBMP-2 on bone regeneration in rabbit calvaria using poly (propylene fumarate) scaffolds. Acta biomaterialia. 2015 May 1;18:9-20.
  • Gustafson CT, Boakye-Agyeman F, Brinkman CL, Reid JM, Patel R, Bajzer Z, Dadsetan M, Yaszemski MJ. Controlled delivery of vancomycin via charged hydrogels. PloS one. 2016 Jan 13;11(1):e0146401.
  • Olthof MG, Kempen DH, Herrick JL, Yaszemski MJ, Dhert WJ, Lu L. Effect of different sustained bone morphogenetic protein‐2 release kinetics on bone formation in poly (propylene fumarate) scaffolds. Journal of Biomedical Materials Research Part B: Applied Biomaterials. 2018 Feb;106(2):477-87.
  • Fang Z, Giambini H, Zeng H, Camp JJ, Dadsetan M, Robb RA, An KN, Yaszemski MJ, Lu L. Biomechanical evaluation of an injectable and biodegradable copolymer P (PF-co-CL) in a cadaveric vertebral body defect model. Tissue Engineering Part A. 2014 Jan 10;20(5-6):1096-102.
  • Hakim JS, Esmaeili Rad M, Grahn PJ, Chen BK, Knight AM, Schmeichel AM, Isaq NA, Dadsetan M, Yaszemski MJ, Windebank AJ. Positively charged oligo [poly (ethylene glycol) fumarate] scaffold implantation results in a permissive lesion environment after spinal cord injury in rat. Tissue Engineering Part A. 2015 Jun 15;21(13-14):2099-114.
  • Chen BK, Madigan NN, Hakim JS, Dadsetan M, McMahon SS, Yaszemski MJ, Windebank AJ. GDNF Schwann cells in hydrogel scaffolds promote regional axon regeneration, remyelination and functional improvement after spinal cord transection in rats. Journal of tissue engineering and regenerative medicine. 2018 Jan;12(1):e398-407.
  • Van der Deen M, Taipaleenmäki H, Zhang Y, Teplyuk NM, Gupta A, Cinghu S, Shogren K, Maran A, Yaszemski MJ, Ling L, Cool SM. MicroRNA-34c inversely couples the biological functions of the runt-related transcription factor RUNX2 and the tumor suppressor p53 in osteosarcoma. Journal of Biological Chemistry. 2013 Jul 19;288(29):21307-19.
  • Reumann S, Shogren KL, Yaszemski MJ, Maran A. Inhibition of Autophagy Increases 2‐Methoxyestradiol‐Induced Cytotoxicity in SW1353 Chondrosarcoma Cells. Journal of cellular biochemistry. 2016 Mar;117(3):751-9.
  • Maran A, Shogren KL, Benedikt M, Sarkar G, Turner RT, Yaszemski MJ. 2‐methoxyestradiol‐induced cell death in osteosarcoma cells is preceded by cell cycle arrest. Journal of cellular biochemistry. 2008 Aug 1;104(5):1937-45.
  • Angius D, Wang H, Spinner RJ, Gutierrez-Cotto Y, Yaszemski MJ, Windebank AJ. A systematic review of animal models used to study nerve regeneration in tissue-engineered scaffolds. Biomaterials. 2012 Nov 1;33(32):8034-9.

 

Categories

  • Biomedical Engineering
  • Civil and Environmental
  • Civil and Environmental Engineering
  • COE Announcements
  • Electrical and Computer Engineering
  • General
  • News
  • UTSA COE

Recent Posts

  • Roadrunners You Should Know: Student demonstrating leadership during first year at UTSA

     JUNE 11, 2020 — First-year Top Scholar an...
  • Five Roadrunner scholars honored with NSF fellowships

     MAY 27, 2020 – Two current UTSA students ...
  • Two Honors College juniors receive prestigious Goldwater scholarship

     APRIL 6, 2020 — UTSA students Naomi ...
  • Bizios elected to the prestigious Academy of Athens

     MARCH 5, 2020 – Rena Bizios,&nb...
  • College of Engineering welcomes key new faculty

     FEBRUARY 6, 2020 — The UTSA College ...

Archives

  • June 2020
  • May 2020
  • April 2020
  • March 2020
  • February 2020
  • January 2020
  • December 2019
  • October 2019
  • September 2019
  • August 2019
  • April 2019
  • February 2019
  • October 2018
  • August 2018
  • July 2018
  • March 2018
  • February 2018
  • January 2018
  • December 2017
  • November 2017
  • October 2017
  • September 2017
  • August 2017
  • July 2017
  • June 2017
  • May 2017
  • April 2017
  • February 2017
  • October 2016
  • July 2016
  • March 2016
  • November 2015
  • October 2015
  • August 2015
  • July 2014

Department of Biomedical Engineering
Applied Engineering Building (AET)
Room 1.102 One UTSA Circle
San Antonio, TX 78249

Phone: 210-458-7084
Fax: 210-458-7007

Contact COE Webmaster: coe@utsa.edu

BME Mission
The Department of Biomedical Engineering is committed to providing a learning environment that encourages discovery and advancement for the betterment of its students and the community. Through its biomedical engineering educational programs, externally funded research and public service, the Department seeks to serve the professional training needs of San Antonio, south central Texas, and beyond. It is committed to developing well-rounded, competitive biomedical engineering professionals to support the University's mission.

UTSA Mission
The University of Texas at San Antonio is dedicated to the advancement of knowledge through research and discovery, teaching and learning, community engagement and public service. As an institution of access and excellence, UTSA embraces multicultural traditions and serves as a center for intellectual and creative resources as well as a catalyst for socioeconomic development–for Texas, the nation and the world.

© 2021 The University of Texas at San Antonio | One UTSA Circle San Antonio, TX 78249 | Information 210-458-4011
Campus Alerts | Jobs | Required Links | Policies | UT System | Report Fraud
Produced by University Communications and Marketing

TOP